In June 2016, JDRF and MannKind announced a research and clinical trial collaboration which will focus upon Afrezza’s safety and effectiveness for pediatric use. This will help Mannkind fulfill commitments the company has made to the FDA to do more testing of the product.
Mannkind Collaborates with JDRF on Afrezza Pediatric Trials
Posted in Glucose & Insulin